Neuphoria Therapeutics Inc. (NEUP): Nasdaq/NYSE listing notice — Nasdaq grants Neuphoria 180-day extension to hold annual meeting, cure listing deficiency

Neuphoria Therapeutics Inc.

Nasdaq accepted compliance plan on Sept 10, 2025; new deadline Dec 29, 2025.
Deficiency for failure to hold annual meeting within 12 months of fiscal year end June 30, 2024.
Company plans to file 10-K by Sept 29, 2025, then proxy and hold meeting within extension.
No financial impact disclosed; listing remains under monitoring.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Neuphoria Therapeutics Inc. received a nasdaq extension granted notice regarding shareholders (rules 5620(a)).

Exchange: nasdaq
Notice: extension granted
Deficiency: shareholders
Rules: 5620(a)

Exact text from the filing

September 10, 2025, Nasdaq provided the Company further notice that is has accepted our Plan and granted the Company an extension of 180 calendar days (the “ Compliance Period ”) from the end of the Company’s fiscal year, or until December 29, 2025, to regain compliance with the Listing Rule. To this end, the Company intends to file its annual report on Form 10-K on or before September 29, 2025, and thereafter, the Company intends to timely file a proxy statement and notice of shareholder meeting related to the Company’s 2025 annual general shareholder meeting, and further intends to hold such

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Neuphoria Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-087950

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.